Literature DB >> 8875297

How to limit the spread of Creutzfeldt-Jakob disease.

D Dormont1.   

Abstract

Transmissible spongiform encephalopathies are rare lethal diseases induced in humans and animals by unconventional agents called transmissible spongiform encephalopathy agents (TSEAs), virions, or prions. Several cases of iatrogenic Creutzfeldt-Jakob disease (CJD) have been reported in the literature after neurosurgery, treatment with pituitary-derived hormones, corneal grafting, and use of dura mater lyophilisates. In a given infected individual, TSEA-associated infectiousness depends on the nature of the organ: the central nervous system has the highest infectiousness, spleen and lymph nodes a medium infectiousness, and organs such as bone, skin, or skeletal muscles do not harbor any detectable infectiousness in experimental models. Transmissible spongiform encephalopathy/prions have unconventional properties; in particular, they resist almost all the chemical and physical processes that inactivate conventional viruses. Therefore, prevention of CJD agent transmission must be taken into account in daily hospital practice. Efficient sterilization procedures should be determined. In tissue and blood donation, donors with a neurologic history must be excluded, and patients treated with pituitary-derived hormones should be considered potentially infected with TSEA and excluded.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875297     DOI: 10.1086/647360

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

1.  Injectable biomaterials for regenerating complex craniofacial tissues.

Authors:  James D Kretlow; Simon Young; Leda Klouda; Mark Wong; Antonios G Mikos
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

Review 2.  Amyloid assembly and disassembly.

Authors:  Edward Chuang; Acacia M Hori; Christina D Hesketh; James Shorter
Journal:  J Cell Sci       Date:  2018-04-13       Impact factor: 5.285

Review 3.  Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review.

Authors:  Alice Roffi; Giuseppe Filardo; Elizaveta Kon; Maurilio Marcacci
Journal:  BMC Musculoskelet Disord       Date:  2013-11-21       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.